Tumour-Derived Reg3A Educates Dendritic Cells to Promote Pancreatic Cancer Progression

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Regenerating islet-derived protein 3A (Reg3A) is implicated in pancreatic inflammation and cancer.
• Reg3A influences cell proliferation, apoptosis, migration, and invasion in pancreatic cancer.
• The immuno-regulatory role of Reg3A in pancreatic cancer progression remains unclear.

Purpose of the Study:

• To elucidate the immuno-regulatory mechanism of Reg3A in pancreatic cancer.
• To investigate how Reg3A modulates tumour-promoting responses via dendritic cell (DC) interaction.
• To identify potential therapeutic targets within the Reg3A signaling pathway.

Main Methods:

• Co-culture of human peripheral blood-derived dendritic cells (DCs) with Reg3A-overexpressing/silenced pancreatic cancer (PC) cells in a Transwell system.
• Assessment of DC surface marker expression (CD80, CD83, CD86), endocytic function, and cytokine production (IL-12p70, IL-23).
• In vivo studies using SCID mice reconstituted with human T cells and injected with PC cells, followed by transfer of Reg3A-educated DCs.

Main Results:

• Tumour-derived Reg3A downregulated CD80, CD83, and CD86 on DCs, increasing their endocytic function.
• Reg3A-educated DCs exhibited inhibited T lymphocyte proliferation and reduced IL-12p70 production, while enhancing IL-23 production.
• In vivo transfer of Reg3A-educated DCs promoted PC progression in SCID mice, indicating a tumour-promoting effect.
• A positive feedback loop involving Reg3A and the JAK2/STAT3 pathway was identified in DCs.

Conclusions:

• Reg3A acts as a tumour-derived factor that impairs dendritic cell differentiation and maturation.
• Reg3A suppresses the anti-tumour immune response by altering DC function, facilitating pancreatic cancer escape.
• Targeting the Reg3A-JAK2/STAT3 pathway in DCs may offer a novel therapeutic strategy for pancreatic cancer.